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Abstract 
 Nurse practitioners (NPs/APRNs) who provide primary care services may be the first line 
providers in situations where adults present with symptoms of memory loss and forgetfulness.   
Though protocols are available for evaluating dementia, specific guidelines for evaluating early 
cognitive changes, Mild Cognitive Impairment (MCI), are lacking. This descriptive research 
project assesses the knowledge, current screening methods, and barriers to screening for MCI by 
nurse practitioners (APRNs) in the state of Georgia.  One hundred and thirty two NPs 
participated in the survey.  Forty-five percent of the participants were unfamiliar with the 
diagnostic category of MCI.  Of the major barriers identified, fifty eight percent of APRNs 
identified not having enough time, thirty-four percent were unsure of the best screening methods, 
and twenty percent of participants were unsure of protocols. Using Spearman rho correlation, MCI 
screening was significantly correlated with completion of continuing education (CEUs) for both 
MCI (rs = .245, p < .006) and dementia (rs = .243, p < .006).  The Spearman’s rho revealed a 
statistically significant relationship between MCI screening and routinely screening for 
depression (rs = .478, p <.000).  The second stage of this project was to develop practice 
protocols for MCI.  A practitioner panel was recruited from the participants in the initial survey.  
The protocol and evaluation algorithm is presented and discussed.    
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Chapter 1 Background and Significance of Proposed project/Intervention 
Introduction 
 Alzheimer’s Dementia (AD) is an irreversible neurodegenerative disease characterized by 
progressive memory deficits that interfere with daily functioning (Roberts et al., 2008). 
According to the World Health Organization (2012), dementia is considered a major public 
health problem of epidemic portion, affecting more that 35.6 million people worldwide.  
Approximately 5.5 million people in the United States have Alzheimer’s Dementia or a related 
dementia (WHO, 2012).  Alzheimer disease is the sixth leading cause of death in the United 
States (Thies & Bleiler, 2013).  The disease impacts individuals and families and has been 
estimated to cost the U.S. health care system in 2012 an estimated $200 billion, including $140 
billion in costs to Medicare and Medicaid (Alzheimer's Association, 2012).  As the number of 
older adults increase in proportion to the total U.S. population, it can be expected that these costs 
will increase exponentially.   This number is expected to increase to an estimated 16 million by 
2050 because of the United States aging population (Thies & Bleiler, 2013).   
 Mild cognitive impairment (MCI) is described as an intermediate stage of memory 
disorder, involving more substantial memory and cognitive decline than  normal aging changes 
but less than the onset of dementia symptoms with its major pathologic changes (Defranceso et 
al., 2010; Roberts et al., 2008).   It is estimated that 12-15 % of MCI patients progress yearly to 
AD compared to healthy older adults (Defranceso et al., 2010; Lopez et al., 2012; Peterson, 
Knopman, & Boeve, 2009).   Because MCI represents a significant risk factor for the 
development of AD, older adults need to be screened early so that interventions can be started to 
delay and possibly slow the potential progression to AD (Reardon & Halverson, 2013; Roberts et 
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al., 2008).  With the passage of the Affordable Care Act of 2010, a new Medicare benefit 
requires an assessment of cognitive functioning in the older adult (Jeffrey, 2012; Patient 
Protection and Affordable Care Act of 2010). Primary care nurse practitioners are expected to 
identify and appropriately treat cognitive disorders as well as other underlying diseases and 
provide the appropriate patient referrals for services and specialists. Primary care nurse 
practitioners need to identify brief screening methods that have good sensitivity and specificity 
for cognitive disorders. Additional education for nurse practitioners will be needed that focuses 
on evidence based practice guidelines outlining appropriate treatments, resources, and referrals 
available to patients and families.   MCI practice guidelines will be vital to maintain and reduce 
health care costs under the new Affordable Care Act. Screening, diagnosis, and treatment are 
important because delaying nursing home placement for even one year could represent a savings 
of $80,000 in nursing home costs (Genworth Executive summary, 2013). 
  Currently clinicians do not readily diagnose dementia during clinic visits using routine 
history and physical examination.  More than 76% of persons with dementia, including many 
with mild but some with moderate dementia, have never received a diagnosis of dementia from a 
physician or nurse practitioner (Boustani, Peterson, Hanson, Harris, & Lohr, 2003; Lin, 
O’Connor, Rossom, Perdue, & Eckstrom, 2013).  The lack of diagnosis of dementia suggests 
insufficient current screening practices by primary care providers. The reason for the inadequacy 
of screening is uncertain and may be associated with multiple factors such as time constraints 
during visits, unawareness of current screening guidelines, insufficient knowledge of available 
screening instruments, and uncertainty by providers in the administration and evaluation of these 
screening instruments.  No research was identified that addressed the reason for lack of diagnosis 
or screening by primary care nurse practitioners.   
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  8 
  Problem Statement or Purpose 
 The purpose of this clinical project was to identify the need and advocate for nurse 
practitioners to assess individuals in primary care for MCI.  Nurse practitioners who are 
providing primary care services are the first line providers in situations where adults present with 
symptoms of memory loss and forgetfulness. The study investigated the knowledge, current 
screening practices, and barriers to screening for Mild Cognitive Impairment in the older adult 
population, aged 65 and older by nurse practitioners in the state of Georgia.  Since the recently 
passed Affordable Care Act requires yearly screening as part of the Wellness benefit for 
Medicare, clinicians will need guidelines to insure quick and efficient methods of screening, 
guidelines of treatment, and when to refer to specialists. Screening for MCI provides an initial 
step towards progression of a correct diagnosis of MCI.   
 The first step in this translational project was to investigate the knowledge, barriers, and 
screening methods used in clinical settings by nurse practitioners.  From this data, practice 
guidelines were developed, and in phase II, interested NPs from the survey were asked to 
provide feedback and implement the newly developed protocol.   There is a lack of information 
for NPs to adequately screen for the diagnostic category of Mild Cognitive Impairment that often 
precedes the diagnosis of dementia.  This diagnostic category of MCI provides a target time to 
initiate further evaluation of underlying medical conditions and to provide treatment in the 
vulnerable older adult population.  
Clinical Questions to be Addressed 
 Evidence based practice questions for this study include four areas of interest.  The 
questions are: 
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1. What percentage of nurse practitioners currently screen for Mild Cognitive 
Impairment yearly in the older adult population aged 65 and older? 
2. What current screening practices for cognitive impairment are used to screen the 
older adult, aged 65 and older? 
3. What barriers do nurse practitioners identify in providing adequate screening for MCI 
in the older adult population? 
4. Which practice variables best explain the level of MCI screening of nurse 
practitioners? 
 
Theoretical Framework 
   Everett Roger’s Change Theory, diffusion of innovations was utilized as the conceptual 
framework for this project. The theory provides a framework to promote the multilevel change 
process necessary to affect change by addressing the inequities in screening and encouraging the 
use and adoption of a new practice guideline or critical pathway (Rogers, 1965).  Mild cognitive 
impairment is a fairly new diagnostic category and many nurse practitioners may be unfamiliar 
with MCI. The identification and assessment of the nurse practitioner’s knowledge of mild 
cognitive impairment, current screening practices performed, and the perceived barriers to 
screening are important areas to address in developing current practice guidelines for clinicians. 
   Roger’s theory describes the patterns of innovations/idea/program adoption, explains the 
mechanism, and assists in predicting whether and how a new invention/idea/program will be 
successful.  Originally published in 1963, it is a descriptive tool providing guidance as to how to 
promote the rate of innovation/program adoptions (Orr, 2003).   
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Everett Roger’s theory is a broad based theory consisting of constructs from 
psychology and sociology and has been used in health care, business, and informatics.  The five 
stages of change theory occur through a social system in a five- step process: 
1.  Awareness:  the targeted population (nurse practitioners) must develop an 
awareness or knowledge base of the idea/program/protocol (MCI, screening 
method). 
2.  Interest:  the population/clinicians develop an attitude toward the   
idea/program/practice protocol (positive or negative). 
3.  Evaluation:  population/clinicians decide whether to engage in the choice or 
use/adopt the program/protocol. 
4.  Interpretation:  population/clinicians implement the idea/program/protocol. 
5.  Adoption:  population/clinicians confirm that the idea/program/protocol will be 
provided (Orr, 2003; Rogers, 1965). 
As more people or clinicians are exposed to an idea successfully, diffusion occurs 
strengthening the impact of the idea.  For example, at the individual level, adopting a health 
behavior idea/innovation usually involves a lifestyle change. At the organizational level, it may 
involve starting a program or changing regulations. At a community level, exposure or diffusion 
can include using the media or advancing policies (Cain & Mittman, 2002). According to Rogers 
(1965), a number of factors determine how quickly, and to what extent, an innovation will be 
adopted and diffused. Diffusion is used to study the adoption of a health behavior and programs 
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  11 
by health practitioners. Diffusions of innovations that promote health requires multilevel change 
that usually takes place in diverse settings, through different strategies (Cain & Mittman, 2002). 
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Chapter 2 Review of Literature and Synthesis 
 A review of the literature was conducted of English articles searching on the key words 
of mild cognitive impairment, prevalence, screening, barriers, primary care, nurse practitioner, 
clinical practice guidelines, and treatments in electronic databases. Databases included CINAHL, 
Medline, Cochrane library, PROQUEST Nursing and Allied Health Sources, and PsychArticles.  
Additional sources were identified in bibliographies of inclusion articles. 
Demographic characteristics and risk factors of MCI 
 The prevalence rate for MCI varies from different population studies in different 
countries.  Based on Windblad’s clinical consensus criteria established in 2004, the prevalence in 
the older adult of MCI in the United States is reported from 21.8% to 28.3% (Katz et al., 2012; 
Manly et al., 2005; Manly et al., 2008; Peterson et al., 2010).  Austria reports a similar MCI 
prevalence rate to the United States of 24% (Fincher et al., 2007).  China’s prevalence rate from 
population studies is estimated from 12.7% to 21.3% (Nie et al., 2011; Xu et al., 2014). Busse, 
Hensel, Guhne, Angermeyer, and Reidel-Heller (2006) report Germany’s MCI prevalence rate of 
17.2% with a high MCI prevalence rate in France estimated at 42% (Aetero et al., 2008).   
 More recent research findings from the Memory and Medical Care Study population 
study in 2011 with community-dwelling older adults, demonstrated a faster rate of cognitive 
decline in MCI for African Americans when compared to non-African Americans (Lee et al., 
2011).  Other population studies have revealed higher dementia rates in African Americans when 
compared to Caucasians (Folstein, Bassett, Anthony, Romanoski & Nestadt, 1991; Heyman et 
al., 1991; Schwartz et al., 2004; Zsembik & Peek, 2001). In the Einstein Aging Study (2012), 
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there appeared to be little difference in MCI prevalence between men (22.2 %) and women 
(21%) (Katz et al., 2012). 
 Several epidemiological studies have investigated the identification of MCI as a risk 
factor towards development of Alzheimer’s dementia and found that dementia symptoms became 
present in MCI patients in about two to three years before conversion  (Ganguli, Dodge, Shen, & 
DeKosky, 2004; Lopez et al., 2012; Roberts et al., 2008; Roberts et al., 2010).   These cohort 
studies suggest that the opportunity to identify MCI cases may be limited to begin therapies if 
not identified early to treat underlying conditions for those patients who are more at risk to 
convert to Alzheimer’s Dementia. Earlier treatment of vascular risk factors and management of 
contributing underlying medical conditions may slow the progression, which has important 
implications for the development of further preventive and interventional therapies. Since 
increasing age is a risk factor for dementia, studies have suggested the importance of routinely 
screening for cognitive changes over time (Ashford et al., 2008; Ganguli et al., 2004). The 
Medicare Annual Wellness visit will insure yearly cognitive evaluations for the older adult.  
 Diagnostic Category of MCI 
 In 2004, the initial MCI standard diagnostic criteria was established at the international 
workshop on Mild Cognitive Impairment in Stockholm (Winblad et al., 2004).  The established 
clinical consensus criteria included evidence of cognitive deterioration for age evidenced by 
cognitive task performance and/or subjective complaints of memory decline by patient and/or 
informant.  The patient was not demented but not at the same cognitive level for persons in the 
same age group, had preserved activities of daily living, and minimal to no impairment of 
complex instrumental activities of daily living (Winblad et al., 2004). 
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 Patients identified with the diagnosis of MCI experience a mild decline in one or more 
areas such as problems with “memory, attention, executive functioning, or visuospatial abilities” 
(Albert et al., 2011, p.271).   Basic activities of daily living and general intellectual functioning 
remain intact.  There may be minimal impairment of instrumental activities of daily living such 
as managing finances, managing medications, driving, or grocery shopping (Aretouli & Brandt, 
2010; DeVriendt et al., 2012; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008). These 
patients often complain of memory problems and do not have any impairment in social function 
(Feldman & Jacova, 2005; Gauthier et al., 2006; Peterson et al., 2010).  The criteria for MCI falls 
into two clinical subtypes of amnestic MCI (aMCI) and non-amnestic (naMCI) which has been 
differentiated primarily for research purposes (Peterson et al., 2009). Amnestic MCI patients 
present with memory impairment and non-amnestic patients present with impairment in a non-
memory area such as problems with attention, executive function, visuospatial ability, or 
language (Ganguli et al., 2004; Gauthier et al., 2006; Peterson et al., 2009). 
 The Diagnostic and Statistical Manual (DSM-IV) criteria for dementia of the Alzheimer’s 
type involves memory impairment and difficulties in one of the following areas: aphasia 
(language problems), apraxia (impaired motor ability), agnosia (failure to recognize known 
objects), or deterioration in executive function (complex tasks such as balancing a checkbook) 
(American Psychiatric Association, 2000).  Dementia refers to a “syndrome that includes a 
deterioration of at least two cognitive functions, including memory, language, visuospatial 
perception, and executive function” (Kiral, Ozge, Sungar, & Tasdelen, 2013, p. 89).   According 
to Kiral et al. (2013), as the disease progresses, neuropsychiatric symptoms appear along with 
the memory impairment.  Overall, the onset of dementia is gradual for most patients.  
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 Yanhong, Chandra, & Venkatesh (2013) provided a systematic review of the 
neuropsychological deficits associated with MCI and the clinical importance for treatment (Level 
I evidence).  There is a wide range of deficits in memory and executive functioning in patients 
with MCI.  It is evident that more studies are needed to continue to identify specific impairments 
that define MCI.  As noted, MCI is associated with an increased risk of progressing to dementia 
and continues to warrant specific diagnostic criteria.  
Benefits of Early Screening 
 The importance of early screening for cognitive impairment is reinforced from the 
requirement for screening as part of the annual Medicare Wellness visit (Cordell et al., 2013; 
Jeffrey, 2012).  From a cost perspective, initial screening can be inexpensive but the evaluation 
of underlying contributing factors may be costly depending on the provider (Borson et al., 2013; 
Jeffery, 2012).  The data on improvement of patient outcomes is lacking either because the 
outcomes were not measured, the study design was lacking, or there have been limited studies 
specifically evaluating persons with MCI (Boustani et al., 2003; Lin, O’Connor, Rossom, 
Perdue, & Eckstrom, 2013; Lin et al., 2013).  Identifying conditions that are treatable such as B 
12 deficiency, folic acid deficiency, hypothyroidism, and depression that may contribute to 
cognitive changes in the older adult are beneficial to early screening (Borson et al., 2013; 
Clarfield, 2003; Cotter, Clark, & Karlawish, 2003). According to Peterson et al. (2009), most 
investigators believe that providers should treat underlying disease processes early and not wait 
until functional impairment is noted.  Failing to recognize early cognition changes in clients may 
result in their performing at-risk behaviors such as operating machinery, driving difficulties, and 
cooking (Ashford, 2008; Lin, Vance, Gleason, & Heidrich, 2012). 
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Problems of Early Screening 
 Receiving a dementia diagnosis could have potential problems such as promoting 
increased anxiety and depression with fears of a patient being able to remain independent.  
Worry about losing one’s independence may include issues about continued job security, driving 
privileges, social isolation from friends, or denial of insurance (Boustiani et al., 2011; Fowler et 
al., 2012; Holsinger et al., 2011). According to Bouson et al. (2013), the potential harms do not 
come from screening itself, but to the conditions uncovered or inaccurate interpretation of the 
information obtained through screening. Potential problems from misdiagnosis of dementia can 
be reduced with repeated screening (Lin et al., 2013).  More importantly would be the 
development of appropriate guidelines for additional evaluations, appropriate referrals, and 
follow-up for early screening practices in those individuals who are screened for MCI.  
 In the recent review of the evidence for the U.S. Preventive Services Task Force, no 
studies were found to confirm or rebut harms to screening (Lin et al., 2013).  If clinicians are 
concerned with the occurrence of false positives from screening, tools with a high specificity rate 
should be used. 
 According to the U.S. Preventive Services Task Force, despite potential problems of 
screening, there is some benefit for caregiver interventions and for medication treatment for AD. 
Medication trials continue with mixed results for MCI to determine if there is a small benefit of 
acetylcholinesterase inhibitors for treatment of MCI.  There is some evidence to support 
cognitive stimulation as a treatment for persons with MCI and mild to moderate dementia (Lin et 
al., 2013).  
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Prevalence of Screening for Cognitive Impairment in Primary Care 
 In reviewing the existing literature, there were no studies investigating the prevalence of 
screening methods used by nurse practitioners in primary care settings for cognitive impairment. 
There were no studies specifically investigating the knowledge of advanced practice nurses in 
screening the older adult and the use of the diagnostic category of MCI.  MCI is a rather new 
diagnostic category with a billing code established in October, 2008 in the International 
Classification of Diseases, 9th revision, Clinical Modification (Center for Disease Control and 
Prevention, 2011).  This diagnostic code may be unfamiliar to primary care nurse practitioners if 
not employed in specialty memory clinics or with neurology services who may evaluate 
dementia patients frequently.  
Barriers to Screening in Primary Care 
 Several studies have identified barriers to early diagnosing of dementia by physicians.  
Physician concerns that are reported in the literature are time required for testing and counseling, 
and concerns about the stigma associated with the diagnosis for patients and families (Boustani 
et al., 2011; Bradford, Kunik, Schulz, William, & Singh, 2009; Justiss et al., 2009).   Primary 
care physicians may fail to diagnose early cognition changes because of failure to use efficient 
screening tools and underreporting of symptoms by family members (Valcour, Masaki, Curb, & 
Blanchette, 2000).  
  Additional studies have looked at barriers to screening for depression and a variety of 
other medical conditions, however, no studies specifically address screening for MCI and nurse 
practitioners.  In screening patients for depression, clinicians identified the importance of having 
clear protocols available for follow-up. Advanced practice nurses identified limited time in 
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screening for depression, limited provider training, knowledge and lack of useful screening 
instruments as barriers to depression screening  (Burman, McCabe, & Pepper, 2005; Goldsmith, 
2007).  In medical screening for colonoscopies, clinicians including nurse practitioners, 
identified barriers to screening as a lack of time and patient reluctance to screening as barriers 
(Feely, Cooper, Foels, & Mahoney, 2009).  Advanced practice nurses have consistently identified 
time limits as a barrier to screening patients for skin cancer (Loescher, Harris, & Curiel-
Lewandrowski, 2011). 
 Considering these identified barriers to screening, having clear protocols, specific 
guidelines as when to refer, and having useful efficient screening tools can contribute to 
reinforcing the need for primary care clinicians to screen for early cognitive changes.  Several 
studies have identified the need for practitioners, physicians and nurses, to identify early subtle 
cognitive changes in clients (Elliott, Horgas, & Marsiske, 2008; Roberts et al., 2010).  
Screening Tools 
   There are brief instruments that can be used in primary care to detect dementia and in 
considering their use for identifying early cognitive changes such as in MCI, higher specificity 
and sensitivity is suggested. Regardless of the etiology of dementia, several instruments have 
sensitivity and specificity rates greater than 80%. The following screening tools are available for 
use with MCI screening. 
 Although there is no one suggested screening tool for MCI, there are several tools that are 
sensitive to detect early cognitive changes when clients score within the normal range of the 
Mini Mental Status Exam (MMSE).  The MMSE is the screening test most frequently used for 
dementia (Cordell et al., 2013).  However, the MMSE is not sensitive enough for screening those 
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with early cognitive changes and those patients will be missed for further work-up (Grober, Hall, 
Liptom, & Teresi, 2008; Holsinger et al., 2012; Stewart, O'Riley, Edelstein, & Gould, 2012).    
  The Montreal Cognitive assessment (MoCA) is a screening tool designed to test for MCI 
with a high sensitivity rate of 90% and a specificity rate of 87% (Cordell et al., 2013; Cullen, 
O’Neill, Evans, Coen, & Lawlor, 2007; Nasreddine et al., 2005).  This tool is specific in 
identifying early cognitive changes in those individuals who perform in the normal range of the 
Mini Mental Status Exam (MMSE).  The MoCA assesses orientation, concentration, attention, 
memory-short term and working, visuospatial ability, executive function, and language (Cordell 
et al., 2013; Cullen et al., 2007; Nasreddine et al., 2005).  The test can be administered in 10 
minutes with a maximum score of 30 and a score of 25 or lower indicating below normal.  The 
test is free and can be accessed at www.mocatest.org. 
 The DemTect is also an easy to administer screening tool and is sensitive for identifying 
early cognitive changes.  It has a sensitivity rate of 80% and a higher specificity rate of 92% 
(Cullen et al., 2007; Kalbe et al., 2004).  Five tasks are measured including memory of word list, 
delayed recall, word fluency, reverse of digits, and transcribing numbers.  With a maximum 
score of 18, scoring for MCI is from 9 to 12 points (Cullen et al., 2007; Kalbe et al., 2004).  
 The Memory and Executive Screening (MES) has a high sensitivity rate of 87% and 
specificity rate of 91% in identifying early cognitive changes and the tool appears to be less 
affected by education.  The test does not require any reading or writing skills. The MES assesses 
delayed recall, delayed memory, learning ability, executive function, and category fluency test. 
The total possible score is 100 points with a score of 62-75 indicating probable MCI, dementia 
correlated with a score of less than 62 (Guo, Zhou, Quian-hau, Wang, & Hong, 2012). 
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 The AB Cognitive Screen (ABCS) was shown to be more sensitive when compared to the 
Mini Mental Status Exam (MMSE) in identifying early dementia changes (Grober et al., 2008).   
This tool evaluates five cognitive areas:  orientation, registration, delayed recall, clock drawing 
and word fluency with a total score of 135 and 104 points indicating MCI (Molley, Standish, & 
Lewis, 2005).  The instrument has a sensitivity rate of 83% and a specificity rate of 91% (Molley 
et al., 2005).  This short screening tool was designed to differentiate normal cognitive changes 
from MCI and dementia. 
 The St. Louis University Mental Status (SLUMS) is an 11 item screening tool that is easy 
to administer and assesses several cognitive domains including attention, calculation, immediate 
and delayed recall, animal naming, abstract thinking and visuospatial skill.  It is more sensitive 
than the MMSE in identifying mild neurocognitive disorder.  It has been studied in the Veteran’s 
population and has a sensitivity rate of 98–100% and specificity 98–100 for dementia with 
adjustment for education but also has a cut off of 25 denoting mild neurocognitive disorder 
(Tariq, Tumosa, & Chibnall, 2006). The SLUMS takes approximately 7 minutes to administer 
with a maximum score of 30 points.  Though the test needs to be studied in non-veteran 
populations, it is recommended to practitioners by the Alzheimer’s Association for use in 
detecting early neurocognitive changes (Cordell et al., 2013; Goy, Kansagara, & Freeman, 2010; 
Tariq, et al., 2006; Stewart, O'Riley, Edelstein, & Gould, 2012).  A comparison list of screening 
tools for MCI is included in Table 1. 
Treatment of MCI and Dementia 
  In consideration of treatment for MCI and dementia, this project is focused on the 
screening of early cognitive changes in the older adult to identify and improve initial evaluation 
and treatment for MCI.  As noted, not all patients with positive screens for MCI will convert to 
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Alzheimer’s Dementia.  This early identification will alert providers to those clients at risk, and 
to initiate further medical and neuropsychological work-up to insure appropriate diagnosis, and 
to treat underlying conditions that affect cognition.  Though outcome data is limited in studies 
with MCI patients, continued research with this specific population is occurring and is providing 
ongoing important clinical treatment data.   
 In treating dementia, a number of pharmacological and non-pharmacological 
interventions have been available for clients and families.  Nondrug interventions for clients 
include cognitive stimulation, exercise, identifying polypharmacy and the possibility of adverse 
side effects, nutritional education, and increased socialization (Geda et al., 2010; Holt, Stiltner, 
& Wallace, 2009). 
 Pharmacological Interventions.  Recent review of multiple drug studies demonstrated 
evidence for the treatment of Alzheimer’s Dementia patients with cholinesterase inhibitors such 
as donepezil, rivastigmine, and galantamine found that these medications were beneficial by 
improving cognition in patients for up to three years. Additional positive benefits and outcomes 
from these medications was the improvement of physical functioning as evidenced by the 
improved performance of activities of daily living (ADLs) (Lin et al., 2013). The benefits for 
MCI patients are unclear because of the small number of studies but the trials did show a 
statistically significant benefit for donepezil and galantamine on improved cognition.  With the 
use of these medications, there was no benefit in the progression to MCI at one and three years 
(Lin et al., 2013).  
 Treatment of Co-Morbidities.  The co-morbidity of medical conditions is important to 
identify when screening clients for mild cognitive impairment.  Anemia has been identified as a 
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predictor of dementia progression and can be easily identified and treated (Blossom, Stephan, 
Brayne, Savva, & Matthews, 2011). Underlying contributing factors such as B12 deficiency, 
hypothyroidism, and depression, which can affect cognition, and are all treatable conditions, may 
improve cognition if identified early and treated appropriately (Blazer, 2009; Borson et al., 2013; 
Clarfield, 2003).  Both depression and cardiovascular diseases (CVDs) are risk factors for 
cognitive impairment which need to be assessed and managed (Barnes, Alexopoulos, Lopez, 
Williamson, & Yaffe, 2006). Vascular risk factors, such as hypertension, smoking, 
cerebrovascular disease, diabetes mellitus, and atrial fibrillation, are also associated with late-life 
cognitive decline (DeCarli et al., 2001; Kivipelto et al., 2001; Solfrizzi et al., 2004). All of these 
risk factors need to be assessed and managed if indicated. 
 Cognitive Interventions.  Stott & Spector (2010) provided a systematic review, 
examining and evaluating memory interventions for MCI (Level I evidence).  Though ten studies 
were identified, there was no consistent evidence to support only one intervention. The studies 
provided some evidence that memory interventions such as memory strategies, i.e., mnemonic 
learning, computerized memory training can improve scores on pre and posttests (Hampstead et 
al., 2008; Scott, & Spector, 2010).  Patient mood, measured in three of the intervention studies, 
did improve in all three which suggested a secondary benefit of providing some sense of control 
and self-efficacy in participants’ lives when experiencing MCI.  There is some evidence that it 
can be helpful to teach internal and external memory strategies to people with MCI (Greenaway 
et al., 2008; Hampstead et al., 2008; Troyer, 2001; Troyer, Murphya, Anderson, Moscovitchade, 
& Craikde, 2008). Cognitive stimulation can also improve and reduce the decline of global 
cognitive function in MCI patients at 6 and 12 months (Lin et al., 2013).  The Advanced 
Cognitive Training for Independent and Vital Elderly (ACTIVE) study demonstrated that 
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cognitive training benefits were evident after ten years of initial reasoning and speed training 
(Rebok et al., 2014). These findings suggest that cognitive training as an intervention may help 
the older adult maintain and improve cognitive abilities.  These long lasting benefits of cognitive 
training will promote independence by sustaining activities of daily living.  
 Caregiver Interventions.  Interventions geared towards caregivers including caregiver 
support, case management, can improve caregiver burden (Lin et al., 2013).  These interventions 
included education about the condition and/or caregiving, caregiver training and skills to deal 
effectively with dementia-related behaviors, and formal avenues of support such as respite 
services, support groups.   Earlier identification through screening identifying those at risk will 
provide earlier avenues for dissemination of information about the condition to patients and 
families, support groups, and advanced planning opportunities. 
 Exercise.  The strongest evidence of lifestyle changes that may reduce the incidence of 
AD is exercise.  Three trials researching the benefits of exercise suggested a benefit in cognition 
in MCI patients and persons with dementia at 12 and 18 months (Lin et al., 2013).  Regular 
exercise lowers specific brain markers in the brain, including reduced CSF tau and increased 
CSF amulod, all markers of decreased AD risk (Liang et al., 2010).   Both aerobic training (AT) 
and resistance training (RT) enhance cognitive performance and functional plasticity, the ability 
of the brain to change and adapt, in healthy, community-dwelling seniors (Nagamatsu et al., 
2012; Stelka, 2013). Exercise is a promising strategy for combating cognitive decline. 
 Maintaining a healthy BMI, body mass index, which is a measure of body fat based on 
height and weight, also plays a role in general and cognitive health.  Several research studies 
demonstrate an association between being overweight with an increased risk of dementia 
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(Narendran, Frankle, Mason, Muldoon, & Moghaddam, 2012; Xu et al., 2011).  Weight 
management and nutrition are important lifestyle changes to prescribe in managing vascular risk 
factors.   
 With the initial screening efforts routinely administered during the annual visit, a 
patient’s life style changes can be discussed with an emphasis on the importance of maintaining 
and improving neurocognitive or brain health.  Educational information can be presented with 
healthier changes identified specific to the patient for improvement of cognition.  Numerous 
lifestyle factors are now being seriously considered by researchers and clinicians because of the 
limited drug treatments available to slow the progression and lack of treatments to modify the 
disease (Caracciolo, Weili, Collins, & Fratiglion, 2014; Lin et al., 2013; Stetka, 2013). 
 Screening Algorithm.  The most recent recommendations from a systematic review, for 
the required annual cognitive screening, is the development of a visit algorithm for the older 
adult during the Annual Medicare Wellness visit (Cordell et al., 2013).  The group developed a 
step-wise approach to screen and evaluate for cognition status suggesting several screening tools 
to assess dementia symptoms. In addition, the second step would be to review the Health Risk 
Assessment that looks at subjective memory complaints or concerns, ADLs and IADLs.  This 
algorithm provides guidelines for clinicians of when to order further testing or when to refer 
(Cordell et al., 2013).  Expert guidelines have recommended along with the US Preventive 
Services Task Force preventive task force to evaluate persons with any memory complaints or 
concerns by informants (Boustani et al., 2003; Cordell et al., 2013).  Early identification of 
memory difficulties with documentation by a provider, may improve follow-up and medical care.  
This time also serves as a beginning to discuss with patients who represent a population at risk 
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for Alzheimer’s dementia about neurocognitive health (Cordell et al., 2013; Feil, MacLean, & 
Sultzer, 2007). 
  It is evident from the synthesis of the literature that more outcome studies need to be 
completed.  More research is indicated in this evolving but very important area of early 
screening.  With the increased prevalence of dementia occurring in this country, the timeliness of 
screening is vital for earlier treatment of risk factors and treatment of underlying medical 
conditions.   
 Though more research is needed, possible benefits of earlier detection of MCI include 
promoting better management of risk factors, delaying functional decline, providing education 
and advanced planning for patients and families, delaying nursing home placement, and 
identifying clients for inclusion in evolving drug and intervention trials (Elliott, Horga, & 
Marsiske, 2008 [Level VI]; Roberts et al., 2010 [Level VI]; Stephan, Brayne, Savva, & 
Matthews, 2011 [Level IV]).   
Guidelines    
 Several agencies have recommended guidelines for cognitive screening based on 
evidence. The focus of this project is screening for MCI, a risk factor for Alzheimer’s Dementia.  
Recommendations from the US Preventive Services Task Force, the recent synthesis for the US 
Preventive Services Task Force 2013, and the National Guideline Clearinghouse Practice 
guidelines, best practices, are included. 
 US Preventive Services Task Force recommendations.  The initial review by the US 
Preventive Services Task Force (2003) found insufficient evidence in benefits for early detection 
and treatment of dementia. The report did not recommend for or against routine dementia 
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screening (Level I evidence).  The report did indicate that assessment for cognitive function is 
indicated when impairment was suspected. Patients who presented with memory complaints need 
to be screened. Often patients with MCI present with memory impairment. 
 Systematic review for the US Preventive Services Task Force (USPSTF), October, 
2013.  The systematic review for the 2013 US Preventative Services Task Force found screening 
improved limited benefits of outcomes for caregivers.  However, the USPSTF concluded that 
there is insufficient current evidence to determine the balance in benefits and harms of screening 
for cognitive impairment (Lin et al., 2013).  The reviewers reported that consensus groups and 
expert guidelines “clearly believes that early diagnosis positively impacts important decision-
making that ultimately will lead to improve patient outcomes and reduced future costs” though 
there was no empirical evidence that screening improved decision making of patients or families 
(Lin et al., 2013, p. 66).  Their review is generally consistent with previous screening 
recommendations, all persons who present with cognitive complaints, self-reported or through an 
informant, should be screened for cognitive impairment (Lin et al., 2013). However, the 
reviewers did report that experts agree that early detection of cognitive changes may be 
beneficial to “optimize” medical treatments of underlying disorders, provide education about the 
condition, encourage important decisions for planning for the future, and providing appropriate 
referrals to needed services, all improving patient outcomes (Lin et al., 2013; Prince, Bryce, & 
Ferri, 2011). They also reported the importance clinically to identify risk factors of persons at 
high risk for cognitive impairments (Lin et al., 2013). 
 From the recent systematic review (2013), studies validate that brief instruments can 
adequately screen for dementia. Six instruments were identified in more than one study to detect 
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MCI.  No studies were found to substantiate or disclaim harms to screening (Lin, O’Connor, 
Rossom, Perdue, & Eckstrom, 2013). 
 National Guideline Clearinghouse Practice guidelines.  Clinical practice guidelines 
available to practitioners for cognitive assessment in the National Guideline Clearinghouse, was 
recently updated in 2012.  Though the target population in the guideline is hospitalized older 
adults, the practice protocol provides a standard to screen and evaluate cognitive function in the 
hospital as well as on the first visit to a new provider, and subsequently could be used in a 
variety of settings such as family practice, long-term care, and assisted living.  The guidelines are 
included in the evidenced based geriatric nursing protocols for best practice that are intended to 
be used by any practitioner (Milisen, Braes, & Foreman, 2012).   
 These initial research studies reinforce the need to develop protocols to screen for mild 
cognitive impairment in the older adult aged 65 and older in primary care.  The Affordable Care 
Act requires assessment of cognitive functioning as part of the annual Medicare wellness visit.  It 
would be important to assess current screening methods, knowledge of mild cognitive 
impairment, barriers to screening, and screening concerns to assist in developing MCI practice 
protocols for nurse practitioners.  Primary care nurse practitioners are pivotal in providing initial 
screening, evaluation and treatment of vascular risk factors, treatment of co-morbid medical 
conditions, and providing timely referrals for the older adult.  
 Though treatments and protocols are available for dementia, protocols for screening and 
evaluation for mild cognitive impairment are limited.  As evidenced in the literature, screening 
tools are available that are sensitive and specific for mild cognitive impairment; but they are used 
inconsistently or not at all in primary care.  Risk factors that contribute to cognitive changes need 
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to be assessed and underlying contributing conditions treated.  Though pharmacological 
treatment for MCI patients is inconclusive, the literature supports modest benefits from cognitive 
interventions, treatment of co-morbidities, and continued monitoring of at risk patients.  
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Chapter 3 Project Description 
  The purpose of this chapter is to describe the methods used.  It will begin with the 
purpose of the study, description of phase one and phase two, research questions identified, 
sample criteria, description of the survey instrument, and the application of Roger’s theoretical 
framework. 
 This project was a clinical practice-based inquiry that in phase I determined the 
knowledge, current screening practices, and barriers to screening of older adults for MCI by 
primary care nurse practitioners. This needs assessment provided data to assist in developing a 
MCI screening protocol and evaluation treatment algorithm for nurse practitioners. After the 
development of the MCI screening protocol, in phase II of the project, participants who indicated 
an interest in the study were invited to participate in evaluating the implementation of the MCI 
protocols in their practice. Members of the pilot study were also invited to implement the MCI 
screening protocol and use of the evaluation algorithm in their practice.  A practitioner panel was 
developed that consisted of those NPs who agreed to provide feedback on the MCI practice 
protocol.  
Problem Statement or Purpose 
  Since the recently passed Affordable Care Act requires yearly screening as part of the 
Wellness benefit for Medicare, clinicians need guidelines to insure quick and efficient methods 
of screening, guidelines of treatment, and when to refer to specialists. Screening for MCI 
provides an initial step towards progression of a correct diagnosis of MCI.   
 There is a lack of information for NPs to adequately screen for the diagnostic category of 
Mild Cognitive Impairment that often precedes the diagnosis of dementia.  This diagnostic 
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category of MCI provides a target time to initiate further evaluation of underlying medical 
conditions and to provide treatment in the vulnerable older adult population. 
Clinical Questions to be Addressed 
 As presented in an earlier section, the evidence based practice questions for this study 
include four areas of interest.  The questions are: 
1. What percentage of nurse practitioners currently screen for Mild Cognitive 
Impairment yearly in the older adult population aged 65 and older? 
2. What current screening practices for cognitive impairment are used to screen the 
older adult, aged 65 and older? 
3. What barriers do nurse practitioners identify in providing adequate screening for MCI 
in the older adult population? 
4. Which practice variables best explain the level of MCI screening of nurse 
practitioners? 
 
Methods 
 This project is a cross sectional study that utilized a web based survey administered to 
nurse practitioners (NPs) in the state of Georgia. Participants were drawn from the Georgia 
Board of Nursing mailing list.  
Recruitment 
 All advanced practice nurses on the Georgia Board of Nursing mailing list were mailed a 
postcard inviting them to participate in the survey. The online link to the survey was included in 
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the information that was provided about the survey on the postcard (see Appendix A for postcard 
invitation).  
Inclusion Criteria 
 The subjects included in the study are advanced practice registered nurses with a 
specialty in family practice, gerontology, or adult health who provide care to the older adult 
population.  The nurse practitioners who are currently employed in a variety of primary care 
settings, clinics, private offices, and public health agencies are included. 
Exclusion Criteria 
 Advanced practice nurses in Georgia who do not care for the target population or are not 
currently working in the role of a nurse practitioner were excluded from the study. Advanced 
practice nurses who do not reside in Georgia were excluded. 
Sample 
  A major concern of the study was generating an appropriate response rate on which to 
base clinical practice guideline development.  Since the Georgia board of nursing does not 
currently have a list of email addresses of nurse practitioners, a mailed invitation to an online 
link was sent to NPs.  Mailed invitations may not offer the most efficient method to invite and 
encourage participation.  A list of mailing addresses was available for a fee, and re-sending of 
the invitation to participates is costly. Currently there are 6,172 NPs who are licensed in the state 
of Georgia (Georgia Board of Nursing, 2014).  No information is available regarding the sample 
size of nurse practitioners who are currently employed in primary care or who provide services 
to the older adult population.    
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 The response rate for web surveys tends to have lower response rates when compared to 
other survey modes (Akl, Maroun, Klocke, Montori, & Schunemann, 2005; Leece et al., 2004).  
The response rate for online surveys overall is approximately 33% as compared to mailed 
surveys which averaged about a 56% response rate (Nulty, 2008). To address the response rate 
concern, an additional effort was made by contacting the Georgia United Advanced Practice 
Registered Nurses (UAPRN) speciality group to provide an invitation on their web site to 
participate in the survey. 
Survey Instrument 
  The 19 item survey was developed by the researcher and assesses the nurse practitioners 
knowledge, current screening behaviors, and perceived barriers to screening patients for 
cognitive disorders (See Appendices B and C). This survey focuses on the Awareness Phase of 
Roger’s Change Theory.  
  Participant characteristics that were assessed include practice setting, certification, 
attendance at continuing educational offering related to dementia, and personal family history of 
dementia or MCI. The following demographic variables were obtained: age, gender, ethnicity, 
employment status, and years of practice. 
   Questions were designed for the readability and clarity of advanced practice nurses.  The 
survey was pilot tested on a sample of 10 practicing NPs who provide care to the older adult 
population.  Their feedback was incorporated into the redesign and clarity of the survey 
questions.  
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Protection of Human Subjects 
 An application and request for approval to conduct this research was made with Georgia 
College and State University’s Institutional Review Board.  A waiver for signed consent was 
requested because the web-based survey research is anonymous with no identifiable information 
collected from the participants. A letter of implied consent was used in the survey instructions 
(See Appendix B). The IRB required a modification to insure that the consent form preceded the 
survey instrument to insure implied consent.  There were no foreseeable risks involved in 
participating in this survey research study other than those encountered in day-to-day life.  The 
results of this survey participation are anonymous. 
 
Informed consent 
  This study is a web based anonymous survey for nurse practitioners in the state of 
Georgia.  The NPs were mailed an invitation to complete the survey online.  A consent form was 
included with the survey instructions explaining consent, risks and benefits of participating in the 
survey research.  By clicking to begin the survey, implied consent was given. By completing the 
survey and submitting, the recipient consents to participate.  This constitutes implied consent and 
no identifiable information was collected from the participants (Refer to Appendix B).  In the 
survey, participants were asked if they would like to receive a copy of the protocols and if they 
may be interested in following the screening guidelines in their practice. They may choose to 
disclose their email address to the researcher and will no longer be anonymous.  This data is 
password protected and will be locked at the Macon Graduate Center for a period of three years.  
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Data Analysis 
 Statistical analysis was performed using SPSS, version 21.  Descriptive statistics was 
used.  For categorical data, frequencies and cross tabulations were performed.  The association 
among variables was assessed using Spearman Rank correlation.   
 After data analysis, this information was used to begin to address the multilevel change 
process necessary to affect change by addressing the inequities in screening and encouraging the 
use and adoption of a new practice guideline or critical pathway (Rogers, 1965).  The five stages 
of Roger’s change theory was used to complete the following stages of the project: 
1.  Increased Awareness:  The information was used to target the population (nurse 
practitioners) and help to develop an awareness or knowledge base of the 
idea/program/protocol (MCI, screening method). The survey will increase 
awareness for screening practices for MCI and identified the need for protocols. 
2.  Interest in screening protocol:  the nurse practitioners/clinicians develop an attitude 
toward the idea/program/practice protocol (positive or negative).  From those nurse 
practitioners who have an initial interest in the study, an email address was 
requested.  Those interested also have a choice of contacting the researcher for 
additional information and to answer questions from the awareness that is 
generated.  From that individual contact, the nurse practitioners were invited to 
participate in using the screening tools and protocols.  From the interactions with 
those interested, attitudes about the survey, screening tools and potential practice 
protocols were initially determined.  
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3. Evaluation:  The nurse practitioners will decide whether to engage in the choice to 
participate in the protocol development.  From the information disseminated from 
contacting those interested in the protocols, they will be asked to participate further 
in the use of the screening instruments/protocols to provide assessment and 
feedback.   
4.  Interpretation:  The nurse practitioners will implement the idea.  If agreed, the 
interested nurse practitioners will implement the screening tools and use the 
practice protocols in their practice.  Feedback will help with the refinement of the 
practice protocols and will be invaluable in continuing to improve the efficiency 
and usefulness of the protocols.  Phase II of feedback from protocol use in the 
project is continuing and feedback is ongoing. 
5.  Adoption:  Nurse practitioners will confirm if the idea is working.  As 
dissemination occurs among those using the screening tools and practice protocols 
successfully, use of the protocols will strengthen the adoption process. Adoption is 
more likely to occur within the practice settings.  Effective and efficient use of the 
screening instruments and protocols will continue to strengthen the adoption 
process (Rogers, 1965; Orr, 2003). 
 Roger’s change theory provides a theoretical framework to assist in promoting change in 
clinical practice.  How can one effect change in practitioners to “buy in” early in a program to 
screen older adults for mild cognitive impairment?  By addressing the five stages of change 
theory, the process helps to identify through a logical process the prediction if a new 
idea/screening methods will be successful. Diffusion expands the number of people who are 
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exposed to the idea, and is strengthened by the successful implementation of the screening 
measures for MCI and use of the protocols (Rogers, 1965). 
 Use of the protocols by NPs in primary care will validate the administration of the 
evidenced based screening tools and usefulness of the MCI evaluation algorithm.  As more NPs 
effectively screen, identify, and treat underlying causes of cognition changes in the older adult, 
protocol use will be strengthened and more practitioners will be exposed to the tools and 
algorithm promoting adoption among practitioners.   
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Chapter 4 
Results 
 The purpose of this clinical project is to identify the need and advocate for nurse 
practitioners to assess the older adult in primary care for MCI. MCI is a risk factor for the 
development of Alzheimer’s Dementia and more than 75% of patients with mild to moderate 
dementia are not diagnosed in primary care.  There may be knowledge gaps in identifying early 
cognitive changes in the older adult by nurse practitioners.  The Affordable Care Act requires an 
evaluation of cognition in the older adult during the annual Medicare Wellness visit.  The NP 
will need sensitive and specific screening tools that can be used efficiently in the primary care 
setting as well an evaluation protocol for MCI which is lacking in the literature.  As stated in 
Chapter 1, the research questions which addressed the purpose of this descriptive study are: 
  1.  What percentage of nurse practitioners currently screen for Mild Cognitive 
 Impairment yearly in the older adult population aged 65 and older? 
 2.  What current screening practices for cognitive impairment are used to screen the older 
 adult, aged 65 and older? 
 3.  What barriers do nurse practitioners identify in providing adequate screening for MCI 
 in the older adult population? 
 4.  Which practice variables best explain the level of MCI screening of nurse 
 practitioners? 
 In phase I of the project, through the web based survey, the knowledge, current screening 
practices, and barriers to screening for MCI in the older adult population, aged 65 and older, by 
nurse practitioners in the state of Georgia were assessed.  From this initial survey data and 
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literature review, initial practice protocols were developed (See appendix D for MCI protocol 
and evaluation algorithm).  In phase II of the project, interested NPs in the survey who disclosed 
their email address or contacted the researcher were sent the proposed MCI practice protocol and 
evaluation algorithm for implementation and feedback. The initial stage of Phase II is complete; 
however, feedback of protocol use is still being invited.   
 The survey data were first examined for error and inconsistencies and then analyzed 
using frequencies and correlations.  Descriptive statistics and correlations were used to answer 
the clinical questions.  Questions 1-3 were answered using frequencies and percentages, question 
4 was answered using correlation.  Data assumptions were met for use of the Spearman Rank 
correlation.  The following section describes the respondent samples, presents frequencies of 
screening practices, and correlates variables associated with MCI screening. 
Description of Sample 
 A total of 5,306 postcards were mailed to Georgia nurse practitioners, sixty six postcards 
were returned by the postal service as undeliverable and 132 APRNs responded to the survey 
with a 2.52% response rate. The researcher received 5 emails from APRNs who did not 
participate in the study because they were not currently practicing an as NP or did not treat older 
adults.  These were subtracted from the initial postcard mailings reducing the mailed sample (N) 
to 5235 nurse practitioners. One hundred forty (140) respondents initially agreed to participate in 
the study, eight did not complete the survey, with a dropout rate of 5.7%.  The total sample (N) is 
132.  Of the 132 respondents, 27% (n=35) identified themselves as adult NPs, 65% (n=85) 
identified themselves as family NPs (FNPs), 8% (n=10) identified themselves as 
geriatric/gerontological (GNPs), and 2 % (n=3) did not respond. Ninety nine (99%, n=131)  
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  39 
respondents indicated they were board certified with 84% (n=111) employed full-time and 16% 
(n =21) employed as part-time working in a variety of practice settings including 42.4% (n=56) 
working in primary care settings, 11.3% (n=15) in acute care clinics, 11% (n=14) working in 
hospitals, 5% (n=6) employed in long term care facilities, 4% (n=5) in public health centers, and 
4% (n=5) working in retail care clinics.  
 The sample of respondents were overwhelmingly female and the racial majority were 
Caucasian with other ethnicities represented.  Specifically, of the 132 participants, 8% (n=11) 
were male and 92% (n=121) were female.  The racial distribution of the sample consisted of 80% 
Caucasian (n =105), 16% African American (n= 21), 2% (n =2) Hispanic and 3% (n=4) 
identified as other.  Thirty-five percent (n=46) of participants had less than five years in practice, 
37% (n=49) had between five and fifteen years of practice experience, and 27% (n=36) had 
greater than 15 years in practice. The age distribution consisted of 4% (n=5) were less than 30 
years of age, 42% (n=55) were between the ages of 30-49, 45% (n=60) fell between 50-65 years 
of age, and 9% (n=12) were over the age of 65 (See Table 2, for demographic descriptions). 
Screening practices  
 When asked about screening practices, 50% (n=64) of the participants reported screening 
for cognitive impairment routinely in the older adult and 65% (n=83) reported routinely 
assessing for depression in the older adult. When screening for dementia 97% (n=120) were 
familiar with the Mini Mental Status Exam (MMSE), 37% (n=46) were familiar with Mini-Cog 
Memory, 11% (n=14) Memory Impairment Screen (MIS), 12% (n=15) were familiar with 
Montreal Cognitive Assessment (MoCA), no respondents were familiar with the DemTect tool, 
2% (n=2) were familiar with the General Practitioner Assessment of Cognition (GPC), 15% 
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(n=18) were familiar with Short Test of Mental Status (STMS), 8% (n=10) were familiar with 
Alzheimer Dementia Screen for Primary Care, 1% (n=1) was familiar with Primary care AB 
Cognitive Screen , 1% (n=1) was familiar with Memory and Executive Screen and 6% (n=8) 
were familiar with the Six Item Screener (SIS). 
 Participants were also asked about routinely screening for depression because depression 
in older adults may present as cognitive impairment.  Twenty percent (n=25) of respondents 
were not familiar with depression screening tools.  Of those who screened for depression, 53% 
(n=68) were familiar with the Beck Depression Inventory (BDI), 34% (n=44) were familiar with 
the Geriatric Depression Scale (34%), 5% (n=6) were familiar with Cornell Scale for Depression 
in Dementia (CSDD), and 37% (n=47) were familiar with the Patient Health Questionnaire 
(PHQ). 
 Thirty two percent (n=41) of respondents reported that they did not screen for MCI. Of 
those practitioners who screen for MCI, 58% (n=74) use the Mini Mental Status Exam (MMSE), 
19% (n=24) use the Mini-Cog Memory Impairment Screen (MIS), 3% (n=4) use the Montreal 
Cognitive Assessment (MoCA), 8% (n=10) indicated other tools including clock test, animal 
naming, St. Louis University Mental Status (SLUMS), and family input. 
Knowledge of Mild Cognitive Impairment 
 When participants were asked how familiar they were with the diagnostic category of 
MCI, 16% (n=20) reported being very familiar, 40% (n=51) responded somewhat familiar, and 
45% (n=58) indicated that they were not familiar with MCI.  Thirty four (n=45) of respondents 
had completed continuing education (CEUs) specific for Mild Cognitive Impairment (MCI) in 
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the past five years with 89% (n=39) of those completing 1-15 CEU credits, 7% (n=3) completing 
16-30 CEU credits, and 2% (n=1) completing greater than 30 CEU credits. 
 Forty one percent (n=54) had completed continuing education in other dementia 
screening specific for Alzheimer’s Dementia, multi-infarct dementia, Lewy Body dementia in 
the past five years.  Ninety-four percent (n=49) completed 1-15 CEU credits, 4% (n=2) 
completed 16-30 CEUs. 
Barriers to Screening 
 When participants were asked to identify barriers to screening, 58% (n=75) reported not 
having enough time, 33% (n=43) reported being unsure of best screening methods, 19% (n=25) 
reported not having enough staff, 15% (n=20) reported that screening tools were too difficult to 
administer efficiently, 20% (n=26) were unsure of protocols, and 20% (n=26) reported no 
barriers to screening.  Fifteen percent (n=19) reported other reasons identified as barriers 
including lack of follow up for results, no clear guidelines in practice of what to do with test 
results, cultural inconsistences, language definitions, patient reluctance, and must be government 
approved (See Table 3 for a summary of identified barriers to screening). 
Personal Involvement 
 Finally, respondents were asked if they had a personal experience with a family member 
having dementia.  Fifty nine percent (n=77) of participants indicated they had personal 
experience of a family member with dementia. 
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Correlations. 
 Analysis of the data was performed using SPSS, version 21.  Correlations were compared 
on the variables of MCI screening, age, specialty, years in practice, knowledge of MCI, 
continuing education credits (CEUs), screening for depression, and personal experience of a 
family member with dementia.  Of all the variables correlated, only the following variables were 
statistically significant.  The Spearman’s rho revealed a statistically significant relationship of 
MCI screening with completion of continuing education (CEUs) for both MCI (rs = .245, p < 
.006) and dementia (rs = .243, p < .006).  Those who completed CEUs for MCI and Dementia 
were more likely to report that they screened for MCI.  The Spearman’s rho revealed a 
statistically significant relationship between MCI screening and routinely screening for 
depression (rs = .478, p <.000). Those participants who were familiar and screened for MCI were 
more likely to screen for depression.  Having experience with a family member having dementia 
was not significantly associated with MCI screening (See Table 4 for correlational data). 
Protocol and Algorithm Evaluation. 
 In phase II of the project, additional data was collected about the interest of participants 
in administering and providing feedback about the practice protocols that would be developed 
for MCI.   A systematic review of evidence of screening for and evaluation of mild cognitive 
impairment in the older adult was performed to develop a screening and evaluation protocol for 
MCI (See appendix D for MCI protocol and evaluation algorithm). During the pilot study, five 
nurse practitioners agreed to follow the developed MCI screening and evaluation protocols 
providing feedback.  All five NPs reported the protocol was easy to follow, liked the information 
provided on the screening tools, and liked the inclusion of the evaluation of recommended blood 
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work studies. For each NP, the MoCA tool was administered to five patients during routine 
physical exams. The NPs reported the ease of administration and scoring of the instrument 
improved with use, initially requiring more time, but much less so as they became familiar with 
the instrument and scoring. From the screening, one patient was referred to neurology and one 
patient was found to have a medical condition contributing to cognitive changes. The St. Louis 
University Mental Status (SLUMS) was administered to two patients and practitioners found the 
tool to be easy and efficient to use, taking less than seven minutes to administer and score.  
 Twenty two respondents from the survey indicated interest in administering and 
providing feedback about the screening tools suggested in the practice protocols by providing 
their email addresses to the researcher.  A copy of the MCI screening protocol and evaluation 
algorithm were sent to all interested participants inviting their feedback.  Six responses have 
been received thus far, all positive comments, agreeing to use the protocols and treatment 
algorithm as a guideline for screening and initial evaluation of cognitive impairment in older 
adults. One email was undeliverable at the address given on the web survey resulting in 21 
emails sent to interested APRNs. This second phase of the study consisting of feedback from use 
of the screening protocol and evaluation algorithm is still ongoing. From the participation thus 
far, dissemination of the MCI screening and evaluation protocol is occurring with potential 
adoption in the future as more patients present with memory complaints or for their Medicare 
annual visit.  
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Chapter 5  Conclusions and Implications 
Discussion of Evidence Based Questions  
 This descriptive study assessed the knowledge, current screening practices, and identified 
barriers by Georgia nurse practitioners for screening of MCI in the older adult.  From the areas 
assessed, practice protocols were developed for use in primary care.  In phase II of the study, 
nurse practitioners interested in the development of practice protocols, were invited to comprise 
a panel to implement the newly developed screening protocol and evaluation algorithm in their 
practice providing feedback.  Though the initial feedback of the implementation of the protocols 
has been received, phase II of the project is ongoing to assess dissemination and adoption phases 
of Roger’s change theory.  
 This section discusses the implications of the results presented in the previous chapter.  
The first question relates to MCI screening practices, perceived barriers to screening, and 
practice variables related to MCI screening.  Next are recommendations related to the findings, 
limitations, strengths of the study, implications of the study, and areas for future research 
discussed.  Each research question is listed with a discussion that follows. 
Screening of MCI 
What percentage of nurse practitioners currently screen for Mild cognitive Impairment 
(MCI) yearly in the older adult population aged 65 and older? 
 Fifty percent of APRNs in this study screen for cognitive impairment with 32% report 
they do not screen for MCI.  Almost half of the respondents were unfamiliar with the diagnostic 
category of MCI which may be a factor in MCI screening. APRNs may not separate MCI from 
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other dementia screening which indicates that additional education efforts would help to increase 
the understanding and screening for MCI.   
 For participants in the study, the implications of these data indicate that there are APRN 
knowledge gaps of Mild Cognitive Impairment (MCI) and screening for cognitive impairments 
in the older adult.  People who have not received training or continuing education for dementia, 
or more specifically, for MCI are not screening. The importance of continuing education and 
exposure to information about MCI was shown to be important for practitioners to screen in their 
practice. The number of older adults are increasing in the United States with the aging of the 
Baby Boomer population.  With the implementation of the Affordable Care Act 2010 and the 
required assessment of cognition during the Medicare Annual Wellness visit, the expected 
screening and management of dementia and more specifically MCI will be increasing. Having 
tools specific and sensitive for MCI as well as an MCI evaluation protocol for guidelines are 
important. Though specific guidelines are available for assessing dementia such as Alzheimer’s 
Dementia, specific guidelines for assessing and evaluating MCI are lacking.  Earlier 
identification of cognition changes would promote more timely evaluations of treatable 
dementias and appropriate referrals. 
What current screening practices for cognitive impairment are used to screen the older 
adult, aged 65 and older? 
 A variety of screening tools are used to screen the older adult for dementia and MCI.  The 
MMSE is the tool most frequently reported to screen for both dementia and MCI followed by the 
Mini-Cog.    Both of these instruments are indicated for dementia screening but are not specific 
or sensitive enough to screen for early cognitive changes as in MCI (Grober, Hall, Liptom, & 
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Teresi, 2008; Holsinger et al., 2012; Kaufer et al., 2008).  Identification of tools with a high 
sensitivity and specificity rate indicated for MCI is important to ensure consistent screening 
efforts in primary care. 
Barriers 
What barriers do nurse practitioners identify in providing adequate screening for MCI in 
the older adult population?   
 The majority of respondents (58%) identified not having enough time as a major barrier 
to screening, followed by unsure of best screening methods (34%). Twenty percent of the 
APRNs/NPs were unsure of protocols, nineteen percent reported not having enough staff, and 
sixteen percent identified that the screening tools were too difficult to administer efficiently.  It is 
interesting that twenty percent reported having no barriers to screening. The obvious is that time 
is the major barrier indicating that quick and efficient screening methods should be adopted.  
From the identification of barriers, a need for the development of protocols was indicated to 
insure screening and appropriate follow-up (See Table 4 for summary of NP barriers to 
screening).  Specifically NPs identified a lack of clear guidelines. 
Which practice variables best explain the level of MCI screening of nurse practitioners?   
 Only the completion of educational CEUs for dementia and MCI correlate with increased 
screening for both MCI and dementia.  The APRNs that participated in continuing education 
units (CEUs) specific for MCI (rs = .245, p < .006) and other dementias (rs = .243, p < .006)    
correlated significantly with increased screening efforts of the older adult.  Knowledge of MCI 
and screening for depression were strongly correlated to an increase in screening for MCI.  
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Educational programs are needed to increase screening efforts for MCI in the older adult.  No 
other practice variable correlated with increased screening for the older adult. 
 It is very concerning and important to note that 20% of respondents were unfamiliar with 
depression screening tools.  A core competency in nurse practitioner curriculum is healthcare 
screening measures which should include screening strategies and tools for depression.  Graduate 
schools of nursing may need to evaluate the competencies being addressed to insure this valuable 
screening content is included. Only the completion of educational CEUs for dementia and MCI 
correlate with increased screening for both MCI and dementia.  Educational programs are needed 
to increase screening efforts for MCI and depression in the older adult.     
MCI Practice Protocol and Treatment Algorithm 
 Since dementia protocols are readily available, efforts in this study were focused on the 
development of MCI protocols for use in primary care.  Older adults are more likely to initially 
present for yearly Medicare Wellness visits which now includes cognitive evaluations or will 
present to their primary care provider with complaints of memory difficulties. From the research 
data, the developed MCI screening protocol and treatment algorithm addressed the barriers, 
identified evidenced based sensitive screening methods, and provided initial medical evaluation 
guidelines including when to refer to neurology or memory disorder specialty clinics for further 
evaluation.  The protocol provides the provider with free to use, sensitive and specific MCI 
screening tools and web resources for depression screening.  Additional evidenced based 
lifestyle changes which offer some limited benefit in patients with MCI are also included in the 
protocol (See Appendix D for protocol and evaluation algorithm). 
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Implications of the Study 
 From the assessment of the identified barriers in the study and in the development of the 
practice protocol, two evidence-based screening tools, the Montreal Cognitive Assessment 
(MoCA) and Saint Louis University Mental Status (SLUMS), are suggested for use in primary 
care.  Both screening tools are easy to administer taking 10 minutes or less and are free for use. 
The SLUMS test can also be administered by ancillary personnel with minimal training reducing 
the time needed by APRNs for direct screening.  Both screening tools had a 90% or greater 
specificity and greater than 80% specificity for MCI. Having efficient and sensitive tools as well 
as practice guidelines are necessary to promote screening practices for MCI particularly in a busy 
primary care office. 
  As important, from the findings of this study, increased continuing education 
opportunities need to be offered for APRNs to improve knowledge of screening and evaluation 
of cognitive impairments of the older adult.  Additional education for APRNs to improve 
knowledge of depression screening tools is also indicated from the research findings.   Use and 
adoption of the MCI practice protocols by those interested NPs identified in the survey remain an 
ongoing phase of this study. The initial feedback received from the NPs indicates a useful 
screening and evaluation protocol to follow in primary care. 
Limitations 
 The major limitations of this study are the small sample size and low response rate.  Only 
mailing addresses were available from the Georgia Board of Nursing which limited recruiting 
efforts of APRNs/Nurse practitioners. Postcards were returned despite checking for current 
mailing addresses, and email addresses were not available. The largest number of nurse 
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practitioners to obtain for this study was through the Georgia Board of Nursing listing. An 
additional effort was made to increase the response rate by contacting the Georgia UAPRN 
specialty group with a direct invitation on their website for NPs who care for older adults to 
participate. Another limitation of this study may be the timing of the collection of data in the 
busy summer months when people may not be readily accessible (Evaluation research team, 
2010). The limited number of weeks for mailings and data collection decreased opportunities to 
increase response rates such as attending state specialty conference meetings which are held 
traditionally in the fall. 
Strengths of the Study 
 This is the first study to develop a survey instrument to investigate the knowledge, 
screening tools, and barriers to screening for Mild Cognitive Impairment by nurse practitioners.  
With the development of practice protocols from the survey results, the dissemination of 
screening for MCI during the annual Wellness visit will impact the care and outcomes for the 
older adult.   
Recommendations for Future Study 
 Recommendations for further study include improving the low response rate by 
identifying other avenues for acquiring nurse practitioner listings for sampling such as specialty 
web sites and social media. Of major importance would be to lobby for the Georgia board of 
nursing to obtain current email addresses of all licensed APRNs so that continued research 
efforts could be encouraged with better participation. Including all APRNs in further research 
who treat the older adults would help to identify trends in screening and evaluation of MCI and 
dementia.  
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 As the population continues to age and the frequency of MCI and dementia increases, 
NPs will need to be prepared to use sensitive screening tools specific for MCI and have access to 
guidelines for evaluation of MCI.  Early screening efforts will promote earlier treatment of co-
morbid conditions, timely referrals for appropriate diagnosis, and interventions started to 
possibly slow the progression of MCI to dementia.  The ultimate goal is to improve the care of 
the vulnerable older adult. 
Conclusions 
 Findings from this translational project suggest that only half of the respondents in this 
survey screen for cognitive impairment with almost fifty percent of APRNs being unfamiliar 
with the diagnostic category of MCI.  Most APRNs who screen for MCI use the Mini Mental 
Status Exam (MMSE) as a major screening tool.  Unfortunately, the MMSE has a ceiling affect 
and is not specific enough to identify early cognitive changes. Though there were differences in 
screening methods used, only a small percentage used tools very specific for MCI screening 
including the MoCA and the SLUMS.  The screening and practice protocol developed for this 
project provides needed guidelines for screening and the initial evaluation of MCI. 
 Because of the use of a convenience sample, generalizability of the findings to NPs in 
Georgia is limited.  However, the data may indicate patterns in screening frequencies, knowledge 
of MCI, and barriers to screening in practice. 
 Development of the MCI protocol and algorithm will provide guidelines for nurse 
practitioners/APRNs to screen and initially evaluate older adults who present with memory 
complaints or during the Medicare Annual Wellness visit which requires assessment of 
cognition.  Future use of the protocol and algorithm will validate its usefulness and reliability in 
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primary care.  Earlier identification of MCI can assist in identifying and treating co-morbid 
conditions, obtaining correct diagnoses, providing patient and family education, and providing 
more efficient and timely referrals with the ultimate goal of improving patient care outcomes of 
the older adult. 
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Table 1 
 
Comparison of Screening Tools for MCI 
 
 
Screening Tool 
 
Sensitivity Specificity Administration Time 
Montreal Cognitive Assessment 
(MoCA) 
90% 87% 10 minutes 
DemTect 80% 92% 8-10 minutes 
 
Memory Executive Screening (MES) 87% 91% 7-9 minutes 
 
AB Cognitive Screen (ABCS) 83% 91% 3-5 minutes 
 
St. Louis University Mental Status 
(SLUMS) 
92% 81% 7 minutes 
Adapted from The Montreal cognitive assessment, MoCA: a brief screening tool for mild 
cognitive impairment by Nasreddine, Z.S., Phillips, N.A., & Bedirian, V., 2005, Journal of 
American Geriatric Society, 53(4), 695-699.; Adapted from Screening for mild cognitive 
impairment:  Comparing the SMMEE and the ABS by Molley, D.W., Standish, T.I., & Lewis, 
D.L., 2005, Canadian Journal of Psychiatry, 50(1), 52-58; Adapted from  Demtect:  a new, 
sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early 
dementia by Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A.P., Brand, M., & 
Bullock, R., 2004.  International Journal of Geriatric Psychiatry 19(2), 136-43.; Adapted from 
A brief cognitive test for detecting mild cognitive impairment by Guo, Q., Zhou, B., Qian-hau, 
Z., Wang, B., & Hong, Z., 2012.  BMC Neurology, 12(119).  Adapted from Comparison of the 
Saint Louis University mental status examination and the mini-mental state examination for 
detecting dementia and mild neurocognitive disorder-a pilot study by Tariq, S.H. Tumosa, N., & 
Chibnall, J.T., 2006.  American Journal of Geriatric Psychiatry, 14(11), 900-910. 
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  68 
Table 2 
Participant Characteristics 
 
Description of the Respondents (n=132) 
Variable                   Percentage %            Variable                Percentage % 
 
Specialty                                           Race 
Adult                 27                              African American     16 
Family      65                              Caucasian            79 
Gerontological      8                              Latin American           2  
                                                    Other                           3 
Gender   
Female     92                  Yrs. in Practice   
Male                   8                               < 5 years             35  
                                                       5-15 years             37 
Age Group                                                                > 15 years             28 
< 30 years                      4 
30 -  49 years               42 
50 – 65 years     45  
65+ years                  9 
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Table 3 
Barriers to Screening 
 
Reported Barriers to Screening  (n=130) 
Response                                           Percentage %             
 
Not enough time                          58%    
                                       
Unsure of best screening methods             33% 
    
Screening tools too difficult to                     15% 
Administer efficiently 
 
Not enough staff                                           19% 
 
Unsure of protocols                                     20% 
 
Other                                                             15% 
 
No barriers                                                    20% 
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Table 4 
Correlations Spearman Rank 
 
Variable MCI 
Screening 
MCI CEU’s Dementia CEU’s Depression 
Screening 
MCI Screening 1    
MCI CEU’s 
Correlation Coefficient 
Sig. (2 tailed) 
N 
 
 
.245** 
.006 
127 
1   
Dementia CEU’s 
Correlation Coefficient 
Sig. (2 tailed) 
N 
 
 
.243** 
.006 
127 
 
.521** 
.000 
131 
1  
Depression Screening 
Correlation Coefficient 
Sig. (2 tailed) 
N 
 
 
.478** 
.000 
125 
 
.247** 
.005 
128 
 
.254** 
.004 
128 
1 
**Correlation is significant at the 0.01 level.  MCI CEUs = Mild Cognitive Impairment 
continuing education units; Dementia CEUs=dementia (Alzheimer’s Dementia, multi-infract 
dementia, Lewy Body dementia) continuing education units. 
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Appendix A:  Postcard Invitation
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Appendix B  Letter for implied consent/Instructions that precede the web survey 
You are invited to participate in a web-based online survey on current screening practices for 
dementia. This is a research project being conducted by Margaret McIlwain, a DNP student at 
Georgia College and State University. The purpose of the study is to develop practice protocols 
for screening of mild cognitive impairment in the older adult.  The survey should take less than 
10 minutes to complete. 
 
PARTICIPATION 
Your participation in this survey is voluntary. You may refuse to take part in the research or exit 
the survey at any time without penalty.  You are free to decline to answer any particular question 
you do not wish to answer for any reason. 
 
BENEFITS 
You will receive no direct benefits from participating in this research study. However, your 
responses may help us learn more about what nurse practitioners need to help them screen for 
cognitive impairments in a busy practice.  From this research, practice guidelines may be 
developed. 
  
RISKS 
There are no foreseeable risks involved in participating in this study other than those encountered 
in day-to-day life. 
 
CONFIDENTIALITY 
Your individual responses will be anonymous and will not be released in any individually 
identifiable form.  Your survey answers will be sent to a link at Qualtrics.com where data will be 
stored in a password protected electronic format where your responses will remain anonymous.  
No one will be able to identify you or your answers, and no one will know whether or not you 
participated in the study.  At the end of the survey, you will be asked if you are interested in 
administering and providing feedback about the screening tools suggested in the practice 
protocols by contacting me by email at margaret.mcilwain@bobcats.gcsu.edu. If you choose to 
provide contact information such as your phone number or email address, your survey responses 
may no longer be anonymous to the researcher. However, no names or identifying information 
would be included in any publications or presentations based on these data, and your responses 
to this survey will remain confidential.  Research at Georgia College involving human 
participants is carried out under the oversight of the Institutional Review Board.   If you have any 
questions or concerns that you wish to address to someone other than the investigator, please 
address questions to Dr. Bradley Koch, GC IRB Chair, CBX 018, GC, (478) 445-0937.  
 
Electronic Consent:  Please select your choice below.  You may print a copy of this  
consent form for your records. Clicking on the agree button indicates that you have read the 
above information.  You voluntarily agree to participate.  You are 18 years of age or older. 
 
 (Source:  http://iscs.gcsu.edu/forms.htm; http://www.mtu.edu/research/administration/integrity-
 compliance/review-boards/human-subjects/consent_forms.html)  
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Appendix C:  Survey Instrument:  Screening Practices of NPs 
 
Nurse Practitioner Survey  
 
1.  Gender: 
 Male _____ 
 Female _____ 
 
2.  Age group: 
 <30 years _____ 
 30–49 years _____ 
 50–65 years _____ 
 65+ years ______ 
  
3.  Race: 
 Caucasian _____ 
  African American _____ 
 Hispanic_____ 
 Other ______ 
 
4. Work Schedule:  
 Full time _____ 
 Part time _____ 
 
5. Board Certified: 
 Yes _____ 
 No _____ 
 
6. Specialty: 
 Family ______ 
 Adult ______ 
  Geriatric_____ 
  Other______ 
  
7.  Years in Practice: 
 <5 _____ 
 5- 15 _____ 
 >15 _____ 
 
8. Practice Setting: 
 Primary Care Office_____ 
 Acute Care Clinic _____ 
 Hospital_____ 
 Public Health Center______ 
 Retail Care Clinic (CVS Minute Clinic, Walgreens) _____  
 Other_________  
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9.  Percentage of patients seen for primary care     ________ 
 Percentage of patients aged 65 years and older ________ 
   
 
10.  Have you completed any Continuing Education (CEU’s) specific for mild cognitive 
impairment (MCI) screening in past five years? 
 Yes ______ 
No ______ 
 
If yes, approximate number of credits earned: 
None _____ 
 1—15 ______ 
 15-30 ______ 
> 30 ______ 
  
  
11.    Have you completed any Continuing Education (CEU’s) in other dementia screening 
(Alzheimer’s Dementia, multi-infarct dementia, Lewy Body dementia) in the past five 
years? 
 Yes____ 
 No____ 
 
 If yes, approximate number of credits earned: 
 None _____ 
 1—15 ______ 
 15-30 ______ 
 > 30 ______ 
 
12.    Do you routinely assess for cognitive impairment in the older adult? 
 Yes _____ 
  No _____ 
 
13.  Are you familiar with the following instruments that can be used for screening for 
cognitive impairment/Dementia? Please check all that apply. 
 Mini Mental Status Exam (MMSE):  Yes_______ No_____  
 Mini-Cog:   Yes_______ No______ 
 MIS:   (Memory Impairment Screen) Yes_____ No______ 
 MoCA:   (Montreal Cognitive Assessment) Yes______ No_____ 
 Dem Tect:  Yes______ No_____ 
 GPC:   (General Practitioner Assessment of Cognition) Yes_____ No_____ 
 STMS:   (Short Test of Mental Status) Yes_____ No_____ 
 Alzheimer Dementia Screen for Primary Care:  Yes_____ No_____ 
 AB Cognitive Screen:  Yes_____ No_____ 
 Memory and Executive Screen: Yes_____ No_____ 
 Other___________ 
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14.  Are you familiar with the diagnostic category of Mild Cognitive Impairment (MCI)? 
 Yes, very familiar _____ 
 Yes, somewhat familiar _____ 
 No _____ 
 
15.  Which of the following tools do you use in your practice to screen for Mild Cognitive 
Impairment (MCI)?  Select all that apply. 
 None, do not screen:  ______ 
 Mini Mental Status Exam (MMSE):  Yes _____ No_____ 
 Mini-Cog:  Yes _____ No_____ 
 MIS (Memory Impairment Screen):  Yes _____ No_____ 
 MoCA (Montreal Cognitive Assessment):   Yes _____ No_____ 
 Dem Tect:  Yes______ No_____ 
 Other___________ 
 
16. Do you routinely assess for depression in the older adult? 
 Yes _____ 
  No _____ 
 
17.  Are you familiar with the depression screening tools?  If yes, please check all that apply. 
 Beck Depression Inventory (BDI):  Yes _____ No_____ 
 Geriatric Depression Scale (GDS):  Yes _____ No_____ 
 Cornell Scale for Depression in Dementia (CSDD):  Yes _____ No_____ 
 Patient Health Questionnaire (PHQ):  Yes _____ No_____ 
  Other__________ 
 
 If yes, what screening methods do you use? 
  Beck Depression Inventory (BDI): Yes_____ No______ 
 Geriatric Depression Scale (GDS): Yes _____ No_____ 
  Cornell Scale for Depression in Dementia (CSDD): Yes _____ No_____ 
  Patient Health Questionnaire (PHQ):  Yes _____ No_____ 
  Other____________ 
 
18.  What types of barriers to screening for cognitive impairments have you experienced in 
your practice? 
 Not enough time_____ 
 Unsure of best screening methods_____ 
 Screening tools too difficult to administer efficiently_____ 
 Not enough staff_____ 
 Unsure of protocols______ 
 Other_____________ 
 No barriers ______ 
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19.  Have you had personal experience of a family member with dementia? 
 Yes_____ 
 No _____ 
 
 
Thank you for your time in completing this survey.  Your responses are very important in the 
development of practice protocols.  If you are interested in administering and providing feedback 
of the screening tools recommended in the practice protocols, please contact me at 
margaret.mcilwain@bobcats.gcsu.edu. or provide an email address and I will contact you. 
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Appendix D:  Evidence Based Practice Protocol and Evaluation Algorithm 
 
Screening for Mild Cognitive Impairment (MCI) in older adults 
I. GOAL:   
A.  To provide initial screening for early cognitive changes 
B.  To monitor cognitive changes in the older adult over time 
C.  To monitor treatment response 
With the passage of the Affordable Care Act of 2010, a Medicare benefit requires yearly assessment of 
cognitive functioning in the older adult (Cordell et al., 2013; Patient Protection and Affordable Care Act 
of 2010). Early screening for MCI is suggested (Borson et al., 2013). 
 
II. Definition: 
Mild cognitive impairment (MCI) is described as an intermediate stage of memory disorder, 
involving more substantial memory and cognitive decline than normal aging changes but 
less than the onset of dementia symptoms  (Defranceso et al., 2010; Roberts et al., 2008).   
It is estimated that 12-15 % of MCI patients progress yearly to Alzheimer’s Dementia (AD) 
compared to healthy older adults (Defranceso et al., 2010; Peterson, Knopman, Boeve, & 
2009).   MCI represents a significant risk factor for the development of AD. Older adults 
need to be screened early so that modifiable risk factors can be addressed, underlying 
conditions that may affect cognition treated, and early referrals can be initiated for 
appropriate diagnosis (Borson et al., 2013; Roberts et al., 2008).  
 
III. Incidence 
The prevalence rate for MCI varies from different population studies.  The estimated 
prevalence of MCI ranges from 3-42% of older adults depending on the definition (Lin, 
O’Conner, Rossom, Perdue, & Eckstrom, 2013; Ward, Arrighi, Michels, & Cedarbaum, 2012).  
 
IV. Etiology 
MCI loss is more cognitive decline than is expected for someone of similar age and does not 
meet the diagnostic criteria for dementia. 
Major subtypes: 
 A.  Amnestic MCI often converts to AD and has been found to have underlying  
 pathology similar to AD (Markesbery et al., 2006). 
 B.  Non-Amnestic MCI may have no underlying pathology or be secondary to 
 cerebrovascular disease, Lewy body dementia, frontotemporal dementia. 
  (Parks, Decarli, Jacoby, & Yonelinas, 2010). 
 
V.  Clinical Features 
A. Memory difficulties, often patients present with complaints of memory loss 
B. Disturbance in language such as difficulty in finding appropriate words, naming 
C. Disturbance in attention, for example difficulty in following conversations 
D. Difficulties in visuospatial skills  (disorientation in familiar surroundings) 
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E. Basic ADLs are intact but patients may have difficulty with more demanding IADLs such 
as handling finances, driving or shopping 
(Albert et al., 2011; Aretouli & Brandt, 2010; Gauthier et al., 2006; Wadley, Okonkwo, 
Crowe, & Ross-Meadows, 2008). 
 
VI.  Screening Tools specific for MCI or Mild neurocognitive Impairment: 
A. MoCA (Montreal Cognitive Assessment) Sensitivity, 90%, specificity 87%, administration 
time approximately 10 minutes (Nasreddine, Phillips, & Bedirian, 2005). 
Free for use.   
    
B. St. Louis University Mental Status (SLUMS) Sensitivity 92%, specificity 81%, 
administration time approximately 7 minutes (Tariq, Tumosa, & Chibnall, 2006). 
Free for use. 
 
If MCI screening is positive, assess mental status and screen for depression. Depression 
is a risk factor for MCI (Blazer, 2009; Gao et al., 2013; Saczynski et al., 2010). 
Suggested screening tool for Depression:  Geriatric Depression Scale, 92% sensitivity 
89% specificity (GDS developed by Yesavage et al., 1983). 
 
VII. Physical Examination 
Review history of memory complaints, assess vascular risk factors, nutritional status, 
medications. Evaluate sleep patterns, insomnia, sleep apnea. Consider drug and alcohol 
history. 
Corroborate if informant present. 
Identify sensory deficits, hearing and vision. 
Perform physical exam. 
 
VIII. Laboratory Studies 
Initial work-up:  CBC, B12 level, thiamine, folic acid, thyroid function tests, electrolytes, 
glucose, BUN/creatinine, liver function tests, U/A.  Consider VDRL, HIV, drug screen if risk 
factors identified (American Geriatrics Society, 2010; Reuben, Herr, Pacala, Pollock, Potter, 
& Semla, 2011).  
 
IX. Treatment 
Treat underlying potential causes of cognition changes such as B12 deficiency, anemia, 
thyroid disease, depression. Treat or refer for identified sensory deficits.  
 
Provide patient education of lifestyle modifications that show some limited benefit: 
A.  Mediterranean Diet (Caracciolo, Weili, Collins, & Fratiglion, 2014; Roberts et al., 
2010; Sofi, Macchi, Abbate, Gensini, & Casini, 2010).  Mediterranean diet 
emphasizes vegetables, fruits, whole grains, nuts, unsaturated fats.   
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B.  Regular exercise (Liang, Mintun, Fagam, & 2010; Lin et al., 2013; Nagamatsu et al., 
2012) Studies report moderate physical exercise such as brisk walking, strength or 
resistance training,  use of exercise machines, aerobics. 
 
C. Cognitive stimulating activities (Hampstead et al., 2008; Lin et al., 2013; Rebok et al., 
2014; Stott, & Spector, 2011) Studies suggest mentally stimulating activities such as 
computer games, computerized memory training, crossword puzzles. 
 
X. Follow-Up:  Indicated by initial screening, physical examination, treatment of potential 
causes of cognition changes, and laboratory studies. If any concerns persist, consider neuro-
imaging of CT scan of brain or MRI for further evaluation or refer to neurology or memory 
clinic for early dementia work-up (American Geriatrics Society, 2010). 
 
XI. Consultation-Referral:  If assessment is positive for MCI after treatment of potential causes, 
refer to neurology and/or memory clinic for comprehensive neurological evaluation and 
neuroimaging. 
 
 
Resources 
Recommended Instruments for Assessing Mild Cognitive Impairment (MCI): 
MoCA (Montreal Cognitive Assessment) 
Access at:  http://www.mocatest.org   OR 
http://consultgerirn.org/uploads/File/trythis/try_this_3_2.pdf 
 
St. Louis University Mental Status (SLUMS)  
Access at:  http://medschool.slu.edu/agingsuccessfully/pdfsurveys/slumsexam_05.pdf 
 
Recommended Instruments for Assessing Depression in the older adult:  
Geriatric Depression Scale  
Access at:  http://consultgerirn.org/uploads/File/trythis/try_this_4.pdf 
 
References 
 
Albert, M., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., . . . 
 Phelps, CH. (2011).  The diagnosis of mild cognitive impairment due to Alzheimer's 
 disease: recommendations from the National Institute on Aging-Alzheimer's Association 
 workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimer’s & Dementia, 
 7(3), 270-279. doi: 10.1016/j.jalz.2011.03.008 
 
American Geriatrics Society, 2010.  A guide to dementia diagnosis and treatment.  Retrieved 
 from 
 http://dementia.americangeriatrics.org/documents/AGS_PC_Dementia_Sheet_2010v2.
 pdf 
 
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  80 
Aretouli, E., & Brandt, J. (2010). Everyday functioning in mild cognitive impairment and its 
 relationship with executive cognition. International Journal of Geriatric Psychiatry, 25, 
 224-233. doi:10.1002/gps.2325 
 
Blazer, D.G. (2009). Depression in late life: Review and commentary. FOCUS: The Journal of 
 Lifelong Learning in Psychiatry, 7(1), 118-136. 
 
Borson, S., Frank, L., Bayley, P. J., Boustani, M., Dean, M., Lin, P., . . . Ashford, J. (2013). 
 Improving dementia care: The role of screening and detection of cognitive impairment. 
 Alzheimer's & Dementia, 9(2), 151-159. doi:10.1016/j.jalz.2012.08.008 
 
Caracciolo, B, Weili, X., Collins, S., & Fratiglion, L. (2014).  Cognitive decline, dietary factors 
 and gut–brain interactions. Mechanisms of Ageing and Development, 136, 59-69. 
 
Cordell, C.B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., . . . Fried, L.B. 
 Medicare Detection of Cognitive Impairment Workgroup. (2013). Alzheimer's 
 Association recommendations for operationalizing the detection of cognitive 
 impairment during the Medicare Annual Wellness Visit in a primary care setting. 
 Alzheimer’s & Dementia, 9(2), 141-150. doi: 10.1016/j.jalz.2012.09.011 
 
Defranceso, M., Schocke, M., Messner, H.J., Deisenhammer, E.A., Hinterhuber, H., 
 Marksteiner, J., & Weiss, E.M. (2010). Conversion from MCI (Mild cognitive Impairment) 
 to Alzheimer’s disease: diagnostic options and predictors.  Neuropsychiatry, 24(2), 88-
 98.  Retrieved from http://www.ncbi.nlm.nih.gov/pubmeb/20605004 
 
Gao, Y., Huang, C., Zhao, K., Ma, L., Qiu, X., Zhang, L., . . . Xiao, Q. (2013). Depression as a 
 risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal 
 studies. International Journal of Geriatric Psychiatry, 28(5), 441-449. 
 doi:10.1002/gps.3845 
 
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R.C., Ritchie, K., Broich, K., . . . Winblad, B. 
 (2006). Mild cognitive impairment. Lancet, 367, 1262-1270. doi: 10.1016/ S0140-
 6736(06)68542-5 
 
Hampstead, B.M., Sathian, K., Moore, A.B., Nalisnick, C., & Stringer, A.Y. (2008).  Explicit 
 memory training leads to improved memory for face-name pairs in patients with mild 
 cognitive impairment:  Results of a pilot investigation.  Journal of the International 
 Neuropsychological Society, 14, 883-889. 
 
Liang, K.Y., Mintun, M.A., Fagan, A.M. Goate, A.M. Bugg, J.M., Holtzman, D.M., . . . Morris, 
 J.C. (2010). Exercise and Alzheimer's disease biomarkers in cognitively normal older 
 adults.  Annals of Neurology, 68(3), 311-318. doi: 10.1002/ana.22096  
 
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  81 
Lin, J.S., O’Conner, E., Rossom, R.C., Perdue, L.A., & Eckstrom, E. (2013).  Screening for 
 Cognitive Impairment in Older Adults:  A Systematic Review for the U.S. Preventive 
 Services Task Force.  Annals of Internal Medicine, 159, 601-612. 
 
Markesbery, W.R., Schmitt, F.A., Kryscio, R.J., Davis, D.G., Smith, C.D., & Wekstein, D.R.  
 Neuropathologic substrate of mild cognitive impairment. (2006).   Archives of  
 Neurology, 63(1), 38-46.  
Nagamatsu, L.S., Handy, T.C., Hsu, C.L., Voss, M., & Liu-Ambrose, T. (2012). Resistance 
 training promotes cognitive and functional brain plasticity in seniors with probable mild 
 cognitive impairment.  Archives of Internal Medicine, 172(8), 666-668.   Retrieved from 
 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514552 
Nasreddine, Z.S., Phillips, N.A., & Bedirian, V. (2005).  The Montreal cognitive assessment, 
 MoCA:  a brief screening tool for mild cognitive impairment.  Journal of the American 
 Geriatrics Society, 53(4), 695-699. 
 
Parks, C.M., Decarli, C., Jacoby, L.L., & Yonelinas, A.P. (2010).   Aging effects on recollection 
 and familiarity:  The role of white matter hyperintensities. Neuropsychology, 19, 1-17. 
 
 Patient Protection and Affordable Care Act of 2010, HR 3590, 111th Cong, Public Law 111-
 148. Retrieved from http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-
 111publ148.pdf 
 
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., . . . 
 Jack, C. (2009). Mild cognitive impairment: Ten years later. Archives of Neurology, 
 66(12), 1447-1455. doi:10.1001/archneurol.2009.266 
 
Rebok, G.W., Ball, K., Guey, L. T., Jones, R. N., Kim, H., King, J. W., . . . Willis, S. L. (2014). 
 Ten‐year effects of the advanced cognitive training for independent and vital elderly 
 cognitive training trial on cognition and everyday functioning in older adults. Journal of 
 the American Geriatrics Society, 62(1), 16-24. doi:10.1111/jgs.12607 
 
Reuben, D.B., Herr, K.A., Pacala, J.T., Pollock, B.G., Potter, J.F., & Semla, T.P. (2011). 
 Dementia. In Geriatrics at Your Fingertips. New York: The American Geriatrics Society. 
 
Roberts, R.O., Geda, Y.E., Cerhan, J.R., Knopman, D.S., Cha, R.H., Christianson, T.J., . . .
 Petersen, R.C. (2010).  Vegetables, unsaturated Fats, moderate alcohol intake, and Mild 
 Cognitive Impairment. Dementia and Geriatric Cognitive Disorders, 29(5), 413-423. 
 
Roberts, R.O., Geda, Y.E., Knopman, D.S., Cha, R.H., Pankratz, V., Boeve, B.F.,. . . Rocca, W. A. 
 (2008). The Mayo Clinic Study of Aging: design and sampling, participation, baseline 
 measures, and sample characteristics.  Neuroepidemiology, 30(1), 58-69.  doi: 
 10.1159/000115751 
 
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  82 
Saczynski, J.S., Beise, A., Seshadri, S, Auerbach, S., Wolf, P.A., & Au, R. (2010). Depressive 
 symptoms and risk of dementia: the Framingham Heart Study. Neurology, 75(1):35-41.  
 
Sofi, F., Macchi, C., Abbate, R., Gensini, G.F, & Casini A. (2010).  Effectiveness of the 
 Mediterranean diet: can it help delay or prevent Alzheimer’s disease? Journal of 
 Alzheimer’s Disease, 20(3), 795-801.  doi: 10.3233/JAD-2010-1418 
 
Stott, J., & Spector, A. (2011).  A review of the effectiveness of memory interventions in Mild 
 Cognitive Impairment. International Psychogeriatrics, 23(4), 526-538. 
 
Tariq, S.H. Tumosa, N., & Chibnall, J. T. (2006).  Comparison of the Saint Louis University 
 mental status examination and the mini-mental state examination for detecting 
 dementia and mild neurocognitive disorder-a pilot study.  American Journal of Geriatric 
 Psychiatry, 14(11), 900-910. 
 
Wadley, V.G., Okonkwo, O., Crowe, M., & Ross-Meadows, L.A. (2008).  Mild cognitive 
 impairment and everyday function:  Evidence of reduced speed in performing 
 instrumental activities of daily living.  American Journal of Geriatric Psychiatry, 16, 416-
 424.  doi:10.1097/JGP.0b013e31816b7303 
 
Ward, A., Arrighi, H., Michels, S., & Cedarbaum, J. (2012). Mild cognitive impairment: 
 disparity of incidence and prevalence estimates. Alzheimer's & Dementia: The Journal of 
 The Alzheimer's Association, 8(1), 14-21. doi:10.1016/j.jalz.2011.01.002 
 
Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M.B., & Leirer, V.O. (1983).  
 Developmental and validation of a geriatric depression screening scale: A preliminary 
 report.  Journal of Psychiatric Research, 17, 37-49. 
 
  
NP SCREENING PRACTICES FOR MILD COGNITIVE IMPAIRMENT 
  83 
 
